🇺🇸 FDA
Pipeline program

Calquence 100 mg film-coated tablets, Calquence 100 mg hard capsules

ACE-WM-001

Phase 2 small_molecule active

Quick answer

Calquence 100 mg film-coated tablets, Calquence 100 mg hard capsules for Waldenström Macroglobulinemia is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Waldenström Macroglobulinemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials